---
$id: https://graph.org.ai/products/commodity/51142518
$type: Product
source: UNSPSC
code: "51142518"
title: "Apomorphine or apomorphinum"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Apomorphine or apomorphinum

**UNSPSC Code**: 51142518
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C17H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N21FAR7B4S, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but generally known as apomorphine, which bears US NIH Compound Identifier 2215. Apomorphine most often comes in base, chloride, diacetate, hydrochloride, and hydrochloride hemihydrate forms. European Medicines Agency schedules Apomorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12923MIG. World Health Organization schedules apomorphine in its Anatomical Therapeutic Chemical (ATC) Classification. Apomorphine or apomorphinum bears US NLM identifiers UMLS ID C0003596 and NCI Concept Code C61639. SMILES: OC1C2C3C4C(N(CCC4CCC3)C)CC2CCC1O.

